A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, ...
4 hours ago
0
0
Australian men are choosing vasectomies in record numbers, with new Adelaide University research revealing a sustained national increase alongside rising cost-of-living pressures and declining birth rates. In the first-of-its-kind ...
5 hours ago
0
0
A cross-disciplinary research team led by Hongjie Dai, director of the Materials Institute of Life Sciences and Energy (MILES) at the University of Hong Kong (HKU) in Shenzhen, has developed a promising near-infrared (NIR) ...
Jul 13, 2026
0
2
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear ...
Jul 11, 2026
0
3512
In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in which the genes TMPRSS2 ...
Jul 9, 2026
0
5
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, can cause aggressive disease at a young age. The discovery paves the way for genetic testing programs ...
Jul 9, 2026
0
3
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published ...
Jul 7, 2026
0
370
One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these ...
Jul 7, 2026
0
28
New research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may affect genes associated with sperm development, raising new ...
Jul 6, 2026
0
5
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
3
